Development of virus-specific CD4+ T cells during primary cytomegalovirus infection

Journal of Clinical Investigation

Volumn 105, Issue 4, 2000, Pages 541-548

  Rentenaar, Rob J ^a   Gamadia, Laila E ^a   Van Der Hoek, Nicolette ^a   Van Diepen, Frank N J ^a   Boom, René ^b   Weel, Jan F L ^b   Dillen, Pauline M E Wertheim Van ^b   Van Lier, René A W ^a   Ten Berge, Ineke J M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Department of Clinical Virology ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOKINE RELEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HUMAN; KIDNEY TRANSPLANTATION; LYMPHOCYTOPOIESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0033998352     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8229     Document Type: Article

References (29)

1. Ploegh, H.L. 1998. Viral strategies of immune evasion. Science. 280:248-253.
2. Ridge, J.P., Di, R.F. and Matzinger, P. 1998. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature. 393:474-478.
3. Zajac, A.J., et al. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-2213.
4. Jonjic, S., Mutter, W., Weiland, F., Reddehase, M.J., and Koszinowski, U.H. 1989. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. J. Exp. Med. 169:1199-1212.
5. Armitage, R.J., et al. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature. 357:80-82.
6. DiSanto, J.P., Bonnefoy, J.Y., Gauchat, J.F., Fischer, A., and de Saint, B.G. 1993. CD40 ligand mutations in x-linked immunodeficiency with hyperIgM. Nature. 361:541-543.
7. Korthauer, U., et al. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature. 361:539-541.
8. Allen, R.C., et al. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 259:990-993.
9. Polic, B., et al. 1998. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J. Exp. Med. 188:1047-1054.
10. van den Horn, G.J., Meenken, C., Danner, S.A., Reiss, P., and de Smet, M.D. 1998. Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV-patients. Br. J. Ophthalmol. 82:988-990.
11. Jacobson, M.A., et al. 1997. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet. 349:1443-1445.
12. Pertel, P., et al. 1992. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J. Acquir. Immune Defic. Syndr. 5:1069-1074.
13. Waldrop, S.L., Pitcher, C.J., Peterson, D.M., Maino, VC., and Picker, L.J. 1997. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J. Clin. Invest. 99:1739-1750.
14. Komanduri, K.V., et al. 1998. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active anti-retroviral therapy in individuals infected with HIV-1. Nat. Med. 4:953-956.
15. Snydman, D.R., et al. 1987. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N. Engl. J. Med. 317:1049-1054.
16. Ho, M., and Dummer, J.S. 1995. Infections in transplant: recipients. In Principles and practice of infectious diseases. G. Mandel, J. Bennet, and R. Dolin, editors. Churchill Livingstone. New York, NY. 2709-2732.
17. Wever, P.C., et al. 1999. Expression of granzyme B during primary cytomegalovirus infection after renal transplantation. J. Infect. Dis. 179:693-696.
18. Boom, R., et al. 1999. A highly sensitive assay for detection and quantitation of human cytomegalovirus DNA in serum and plasma by PCR and electrochemiluminescence. J. Clin. Microbiol. 37:1489-1497.
19. Boom, R., et al. 1990. Rapid and simple method for purification of nucleic acids. J. Clin, Microbiol. 28:495-503.
20. Akrigg, A., Wilkinson, G.W., and Oram, J.D. 1985. The structure of the major immediate early gene of human cytomegalovirus strain AD169. Virus Res. 2:107-121.
21. Emery, V.C., Cope, A.V., Bowen, E.F., Gor, D., and Griffiths, P.D. 1999. The dynamics of human cytomegalovirus replication in vivo. J. Exp. Med. 190:177-182.
22. Maino, V.C., and Picker, L.J. 1998. Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry. 34:207-215.
23. Bucy, R.P., et al. 1999. Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J. Clin. Invest. 103:1391-1398.
24. Picker, L.J., et al. 1993. Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selection on T cells during the virgin to memory cell transition. J. Immunol. 150:1105-1121.
25. Hamann, D., Baars, P.A., Hooibrink, B., and van Lier R.A.W. 1996. Heterogeneity of the human CD4+ T-cell population: two distinct CD4+ T-cell subsets characterized by coexpression of CD45RA and CD45RO isoforms. Blood. 88:3513-3521.
26. Baars, P.A., Maurice, M.M., Rep, M., Hooibrink, B., and van Lier, R.A.W. 1995. Heterogeneity of the circulating human CD4+ T cell population. Further evidence rhar the CD4+CD45RA-CD27-T cell subset contains specialized primed T cells. J. Immunol. 154:17-25.
27. de Jong, R., et al. 1992. The CD27-subset of peripheral blood memory CD4+ lymphocytes contains functionally differentiated T lymphocytes that develop by persistent antigenic stimulation in vivo. Eur. J. Immunol. 22:993-999.
28. Bird, J.J., et al. 1998. Helper T cell differentiation is controlled by the cell cycle. Immunity. 9:229-237.
29. Waldrop, S.L., Davis, K.A., Maino, V.C., and Picker, L.J. 1998. Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis. J. Immunol. 161:5284-5295.